Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Receives Average Rating of "Buy" from Analysts

Key Points

• Reckitt Benckiser Group PLC has received a consensus recommendation of "Buy" from analysts, with seven firms covering the stock, including one hold, two buy, and four strong buy ratings.
• The company's stock price recently opened at $15.42, with a one-year range between $11.73 and $15.55, indicating a positive trend in valuation.
• Reckitt Benckiser Group recently announced a dividend of $0.2106, which will be paid on September 25th, and has a significant dividend yield of 341.0%.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) has received a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, two have given a buy recommendation and four have given a strong buy recommendation to the company.

Several analysts have commented on RBGLY shares. Sanford C. Bernstein raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, July 25th.

Reckitt Benckiser Group Stock Up 0.7%

RBGLY stock opened at $15.42 on Monday. The firm has a 50-day simple moving average of $14.56 and a two-hundred day simple moving average of $13.76. Reckitt Benckiser Group has a one year low of $11.73 and a one year high of $15.55. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37.

Reckitt Benckiser Group Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, September 25th. Investors of record on Monday, August 11th will be given a $0.2106 dividend. This represents a dividend yield of 341.0%. The ex-dividend date of this dividend is Friday, August 8th.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.